CTKB Cytek Biosciences, Inc.
Executive Summary
An institutional cluster in Cytek Biosciences (CTKB) for Q3 2025 shows mixed conviction: two passive managers added $1.4M in net buying while four institutions (including Citadel and RenTech) reduced holdings by $3.6M. The overall net selling pressure of ~$2.2M suggests institutional disinterest despite a 70% analyst buy rating, with the largest single sell being Citadel's near-exit (-86.7%).
Key Financial Metrics
Institutional Positions
Net institutional flow: -$2.2M
▲ Buyers (2)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | ADD | +27.2% | $5.1M | $1.2M |
| BofA | ADD | +85.7% | $590.0K | $279.0K |
▼ Sellers (4)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Citadel | NEAR_EXIT | -86.7% | $2.1M | -$1.8M |
| UBS | TRIM | -25.8% | $2.1M | -$522.6K |
| RenTech | TRIM | -25.2% | $3.6M | -$854.1K |
| Legal & General Group | TRIM | -38% | $1.1M | -$387.4K |
Actionable Insight
The cluster shows a clear divergence between passive rebalancers (adding) and active/quant funds (reducing). With Citadel and RenTech both trimming meaningfully, legacy long-only pressure is being absorbed by passive flows. Monitor Q4 2025 13F filings for continuation — if further quant selling occurs without passive absorption, downward pressure could accelerate. The ~$2.2M net outflow is small vs. $523M market cap (<0.5%), but the directional signal from sophisticated quant managers warrants attention.
Key Facts
- 2 passive buyers added $1.47M (Morgan Stanley +$1.2M, BofA +$279K)
- 4 institutional sellers reduced by $3.58M total
- Citadel nearly exited (-86.7% of shares, selling $1.8M)
- Renaissance Technologies trimmed -25.2% (-$854K)
- UBS trimmed -25.8% (-$523K)
- Legal & General trimmed -38.0% (-$387K)
- Net institutional flow was -$2.18M against a $523M market cap
- Sellers were a mix of quant (Citadel, RenTech) and passive/asset-manager (UBS, L&G)
Financial Impact
4 institutional sellers reduced holdings by $3.58M while 2 passive buyers added $1.47M, for a net institutional outflow of ~$2.18M in Q3 2025
Risk Factors
- 45-day 13F reporting lag: positions may have already changed
- Small net dollar flow relative to market cap — limited price impact potential
- Cluster dominated by passive buyers, which carry weaker signal than active conviction
- Historical calibration shows negative average alpha at T+20 for this filing segment (-2.04%)
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CTKB-2025-Q3 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
2d ago
|
3
| $3.97 awaiting T+1 | awaiting T+1 | — | — |
|
Jun 11, 2026
3d ago
|
Institutional Cluster
| $4.00 awaiting T+1 | awaiting T+1 | — | — |
|
Jun 2, 2026
12d ago
|
8-K
| $4.05 $4.33 | ▲ +6.91% | ▲ +6.51% | — |
|
Apr 28, 2026
6w ago
|
DEFA14A
| $4.44 $4.56 | ▲ +2.70% | ▲ +1.68% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access